pargyline has been researched along with Cardiovascular Stroke in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dănilă, MD | 1 |
| Privistirescu, AI | 1 |
| Mirica, SN | 1 |
| Sturza, A | 1 |
| Ordodi, V | 1 |
| Noveanu, L | 1 |
| Duicu, OM | 1 |
| Muntean, DM | 1 |
| Faraj, BA | 1 |
| Dayton, PG | 1 |
| Camp, VM | 1 |
| Wilson, JP | 1 |
| Malveaux, EF | 1 |
| Schlant, RC | 1 |
2 other studies available for pargyline and Cardiovascular Stroke
| Article | Year |
|---|---|
Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction.
Topics: Animals; Clorgyline; Female; Ischemic Preconditioning, Myocardial; Male; Monoamine Oxidase Inhibitor | 2015 |
Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.
Topics: Adult; Animals; Chromatography, Thin Layer; Coronary Vessels; Dogs; Erythrocytes; Female; Femoral Ve | 1977 |